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Severe bone disease and low bone mineral density after juve- disease is a common, often disabling, complication of
nile renal failure. end-stage renal disease (ESRD) [1–4]. Chronic acidosis
Background. Little is known about the late effects of juve- and hypovitamin-D– and phosphate-induced secondarynile end-stage renal disease (ESRD) on bone integrity. To
hyperparathyroidism can lead to disturbed bone model-establish clinical manifestations of metabolic bone disease and
bone mineral density (BMD) in young adult patients with juve- ing with high or low bone turnover in patients on chronic
nile ESRD, we performed a long-term outcome study. dialysis [5–8]. In addition, inactivity during chronic dial-
Methods. A cohort was formed of all Dutch patients with ysis and corticosteroids, mainly given chronically as anti-onset of ESRD between 1972 and 1992 at age 0 to 14 years,
rejection therapy after transplantation, may lead to os-born before 1979. Data were collected by review of medical
charts, current history, physical examination, and performing teoporosis [9–14]. In children with ESRD, malnutrition,
dual energy x-ray absorptiometry (DEXA) of the lumbar spine reduced bioactivity of insulin-like growth hormones and
and the femoral neck. delayed puberty can aggravate these effects, disturbingResults. Clinical information was retrieved in 247 out of 249
normal bone formation and growth [15–20]. Little is knownpatients. Of all of these patients, 61.4% had severe growth
retardation (2 SD), 36.8% had clinical symptoms of bone about the effects of ESRD of childhood on bone forma-
disease, and 17.8% were disabled by bone disease. Growth tion at adult age, and about the extent of clinical bone
retardation and clinical bone disease were associated with a disease in long-term survivors of juvenile ESRD.long duration of dialysis. DEXA was performed in 140 out of
We conducted a national long-term follow up study in187 living patients. Mean BMD  SD corrected for gender
order to evaluate Late physical, social and psychologicaland age (Z score) of the lumbar spine was 2.12  1.4 and
of the femoral neck was 1.77  1.4. A low lean body mass Effects of Renal Insufficiency in Children (LERIC Study).
was associated with a low lumbar spine and a low femoral The cohort consisted of all Dutch children who had com-neck BMD; male gender, physical inactivity and aseptic bone
menced RRT between 1972 and 1992 and who had reachednecrosis were associated with a low lumbar spine BMD.
Conclusion. Bone disease is a major clinical problem in young (or would have reached if still alive) adulthood at the
adults with pediatric ESRD. Further follow-up is needed to time of investigation. This article reports the impact on
establish the impact of the low bone mineral densities found growth, the incidence of fractures, clinically apparent bonein these patients.
disease and bone densities measured by dual energy x-ray
absorptiometry (DEXA) in these young adults with pedi-
atric onset of ESRD.As life expectancy has increased in children with chronic
renal replacement therapy (RRT), concern has arisen
about its late complications. In adults, metabolic bone METHODS
Study design
Key words: bone disease, osteoporosis, end-stage renal disease, chil-
dren, pediatric renal failure, metabolic bone disease, LERIC Study. The study was designed as a cohort study and consisted
of two parts: a cross-sectional and a retrospective study.
Received for publication October 1, 2001
The aim of the cross-sectional study was to establishand in revised form August 19, 2002
Accepted for publication August 21, 2002 current health status and to measure bone mineral den-
sity of the lumbar spine and femoral neck, in order to 2003 by the International Society of Nephrology
266
Groothoff et al: Bone disease and osteoporosis after juvenile CRF 267
detect osteoporosis. The aim of the retrospective part of tion, the age at onset of RRT, and the period of onset
of RRT. All medical charts of all patients, participantsthe study was to establish the extent of clinically apparent
metabolic bone disease since the start of RRT, and to as well as non-participants in the cross-sectional study,
were reviewed. Emigrated patients were located andevaluate the influence of a set of predefined determinants
on outcome parameters. The study covered the total medical information was obtained from their current
physician. “Clinical bone disease” was considered pres-period of renal replacement therapy for each patient.
The end of the study was marked by the day of last ent in cases where at least one of the following conditions
occurred: deforming bone abnormalities, chronic painchart review for potential non-participants in the cross-
sectional study and the day of the cross-sectional exami- related to the skeletal system, disabling bone abnormali-
ties, aseptic bone necrosis and atraumatic fractures. Dis-nation for participants. The medical ethical committees
of all participating centers approved the study. abling bone abnormalities were scored as “mild” if the
patient was disabled, but their main functions (walking,
Formation of the cohort writing) were preserved. For instance, patients who were
not able to walk for more than 100 m or in whom motorThe LERIC cohort comprises all Dutch patients who
had started chronic RRT at age 0 to 14 years between functions were hindered by pain, all caused by metabolic
bone disease, were included in this category. Severe dis-1972 and 1992, and who were born before 1979. Patients
in whom renal function recovered within four months abling bone abnormalities referred to those conditions
in which the main motor functions were impaired byafter commencing dialysis were excluded. Preemptively
transplanted patients were included. Patients who started bone disease (walking, standing up), or to conditions in
which patients were chronically dependent on specialRRT after 1991 were excluded in order to have at least
a (potential) follow up period of six years. The National devices (for example, cervical braces, external fixtures).
Motor disabilities caused by neurological disorders orDutch Registry of patients on RRT (RENINE, Rotter-
dam, The Netherlands) submitted a list of patients, based extreme fatigue were excluded, unless the neurological
deficit was the result of metabolic bone disease (for ex-on these criteria. RENINE, founded in 1985, is the Dutch
source of the European Dialysis and Transplantation ample, spinal cord lesion by spine fracture).
Association. The completeness of this database approach
Bone mineral densities100% as registration is compulsory for reimbursement
of RRT. All patients alive were invited once for examination
in our hospital. Height was measured with a fixed stadi-Retrospective registration of patients with RRT start-
ing before 1985 was checked by comparing the RENINE ometer. Bone mineral density and Dual Energy X-ray
Absorptiometry (DEXA, QDR 4500A; Hologic Inc.,data with the databases of all Dutch centers for pediatric
dialysis and kidney transplantation as well as the data- Waltham, MA, USA) established lean body masses. We
assessed bone mineral densities of the femoral neck andbases of all centers for adult dialysis and transplantation.
The procedure of cohort formation was as follows: the the lumbar spine at L1-L4. Bone mineral density (BMD)
was defined as bone mineral content, divided by thelist submitted by RENINE consisted of only registry
numbers of patients, treatment modality, and the name surface of the projected bone area, expressed in g/cm2.
As determinants with respect to bone mineral density,of the last physician and hospital of treatment. All nephrol-
ogists in the Netherlands received a list of those cohort we considered: physical inactivity, gender, height, lean
body mass, modality of RRT at time of investigation,patients who were under their treatment or had been
under their treatment at the time of death. The LERIC- total duration of renal replacement therapy, total dura-
tion of dialysis, age of onset of RRT, period of onset ofteam contacted all of the physicians to ask if the list sent
by RENINE was consistent with the physicians’ registry RRT (that is, 1972 to 1981 versus 1982 to 1992), the period
between transplantation and bone density measurements,database. Patients were contacted by their own physi-
cians and invited to take part in this study. severe hyperparathyroidism, age of menarche in women,
the cumulative steroid dosage, aluminum-containing phos-
Data collection: Clinical bone disease phate binders, growth-hormone therapy, and a history
of aseptic bone necrosis.Between November 1998 and August 2000 members
of the LERIC team visited 37 hospitals in The Nether- Most data on determinants were collected retrospec-
tively as mentioned earlier in the “Clinical bone disease”lands. They collected information about the occurrence
of bone disease (pathological fractures, deformities caused section.
Other information, such as age of menarche in womenby metabolic bone disease, severe chronic bone pain,
aseptic bone necrosis and handicaps caused by bone dis- and physical inactivity, was collected during interview
of the patient. Information about physical activity wasease) and determinants with respect to these outcomes.
The predefined variables were: total duration of RRT assessed using parts of the MOS-RAND 36 question-
naire (question number 3b: “does your health now limitand of hemodialysis, peritoneal dialysis and transplanta-
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you in moderate activities?” and question number 3h: test. Pearson’s correlation was assessed between BMD Z
scores of lumbar spine and femoral neck and all potential“does your health limit you from walking several
blocks”), which applies to a limited physical activity. The determinants, except those who were only measured in
subgroups (that is, menarche and the period betweenMOS-RAND 36 is a widely used tool for quality of life
assessment [22]. It was assumed that true daily physical the last transplantation and moment of investigation in
transplanted patients). All significant determinants (setactivity was correlated with the subjectively scored abil-
ity of physical activity. “Physical inactivity” was scored at P  0.2) identified from these univariate analyses
were studied with a linear stepwise multiple regressionpositive if both questions were answered with “yes.”
Since the exact dosage of corticosteroids was not al- using the F-statistics with P  0.05 as criterion for selec-
tion. We used the regression coefficient relating leanways documented reliably, we scored the total time in
days of which we were sure that the prescribed prednisone body mass with both lumbar spine and femoral neck
BMD and the difference in lean body mass betweenor prednisolone dosage exceeded 0.25 mg/kg per day. We
also scored the total time of alternate day prescription of patients and controls to calculate the predicted BMD
and Z score, adjusted for lean body mass.more than 0.25 mg/kg. Since all courses of “high-dose”
methylprednisolone, given as anti-graft-rejection ther-
apy, were prescribed according to well-defined protocols,
RESULTS
we were able to express the total cumulative dosage of
The cohort“high dose” methylprednisolone in mg/kg. The cumula-
tive dosage of corticosteroids was estimated by calculat- The RENINE database produced a list of 251 patients
who fulfilled the inclusion criteria. Checking with theing the total amount of predniso(lo)ne, assuming that the
mean dosage of prednisone would have been 0.5 mg/kg local databases of all participating centers revealed the
following information: one patient was mentioned twiceduring the scored period. Then, the cumulative IV meth-
ylprednisolone dosage was added to the estimated oral and three patients did not meet to the inclusion criteria.
Reviewing the databases of all dialysis and transplanta-steroid dosage. When applicable, duration of growth hor-
mone therapy was established. Severe hyperparathyroid- tion centers produced two extra patients. According to
RENINE, 7 out of 251 patients were lost to follow-up;ism was scored “positive” if parathyroid hormone had
ever exceeded three times the normal value over a cumu- six of these patients appeared to be alive and one patient
had passed away. Thus, the final cohort consisted oflative period of more than 12 months, or if a parathyroid-
ectomy had been performed. Body height and clinical 249 patients. Of these, at time of the study, 63 patients
(25.3%) had died; one of them died four months afterbone abnormalities in patients who participated in the
cross-sectional study were assessed by physical examina- the cross-sectional investigation, and was included as
participant. No patients were lost to follow-up. Of all oftion and interview. These data were combined with data
derived from the medical charts. Determinants of bone the LERIC patients, a total of 3870 patient-years was
recorded, covering the entire period from the onset ofdisease of all the patients and data about clinically appar-
ent bone disease, growth, disabilities and atraumatic frac- RRT until August 2000 or time of death, with 81 patient
years missing and with an average follow up of 15.5 yearstures of non-participants and deceased patients were as-
sessed from the medical charts. per patient. Of the two patients (0.8%) who both died
in 1974, no clinical data on bone disease could be found.
Control values The main characteristics of all the patients are listed in
Table 1. Of the 187 patients alive, 47 (25.1%) declinedControl values of weight and height were derived from
the National Dutch Health Statistics (http://www.cbs.nl), to participate in the cross-sectional study, leaving a total
of 140 subjects. No significant differences were found inof lean body mass from data of Boot et al [23]. BMD
values were compared with control values of European age, gender, age of onset of RRT and therapy character-
istics between participants and non-participants of theand American subjects, supplied by Hologic Inc.
cross-sectional study.
Statistical analysis For logistical reasons, lumbar spine and femoral neck
DEXA mass was not performed in 4 out of 140 (2.9%)The relation between clinical bone disease and its de-
terminants was analyzed using the Student t test for con- subjects. In two patients, DEXA measurement of the
femoral neck was not possible because of a hip prosthesis.tinuous variables with a normal distribution, and with
the chi-square test for nominal variables. A comparison
Clinical bone diseaseof nominal variables of participants and non-participants
of the cross-sectional study was performed by the chi- The mean height of all the patients was 160.6 cm (range
138.5 to 185). Severe growth retardation (SD 2.0)square test. The relationship between Z scores of BMD
and dichotomous determinants were analyzed by using was seen in 61.4% of all LERIC patients. Clinical mani-
festations of bone disease had occurred in 36.8%, andthe Student t test, or if applicable the Mann-Whitney
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Table 1. Patient characteristics A lumbar spine Z score of less than1 SD, consistent
with osteopenia, was found in 111 (81.6%) of all 136Total cohort
patients measured; 52 patients (38.2%) had a lumbarPatients N 249
Male N 136 (54.6%) spine Z-score of less than 2.5 SD. Of 134 patients, 104
Primary disease N (77.6%) had a femoral neck Z score of less than 1 SD
Glomerulopathy 90 (36.1%)
and 51 (38.1%) had a femoral neck Z score of less thanObstructive uropathy 70 (28.1%)
Congenital renal malformationb 44 (17.7%) 2.5 SD. Of all 136 patients, 121 (89.0%) had at least
HUS 18 (7.2%) in one segment a BMD Z score of less than 1 SD and
Metabolic diseasec 8 (3.2%)
71 (52.2%) had at least in one segment a BMD Z scoreSLE 5 (2.0%)
Other 14 (5.6%) of less than 2.5 SD.
Age at onset of RRTa years 10.6 (range 1.9–14.9)
Age at time of investigation years 29.3 (range 20.7–41.7) Determinants of bone mineral density
Deceased N 63 (25.3%)
Duration of RRT years 16.0 (range 0.3–31.1) No relationship was found between the age at com-
Duration of dialysis years 4.1 (range 0–25.6) mencement of RRT, period of onset of RRT (1972-1981
Duration of transplantation years 11.7 (range 0–29.9)
vs. 1982-1991), total duration of RRT, total duration ofStart RRT 1972–1981 N 151 (60.6%)
dialysis, age of menarche in women and severe hyper-a RRT, renal replacement therapy
b Renal dysplasia, cystic disease, Alport syndrome, nephronophtisis, congenital parathyroidism on the one hand, versus bone mineral
nephrotic syndrome values on the other hand. Significantly lower mean Zc Oxalosis (3), cystinosis (5)
scores of the lumbar spine were found in male, compared
with female patients, in patients with physical inactivity
compared to those with normal activity, and in patients
who received a renal transplant less than three years agomotor handicaps, caused by metabolic bone disease in
17.8% of all patients. Mild disabilities were seen in compared to those who lived for more than three years
with a functioning renal graft at time of investigation.10.5%, severe disabilities in 7.3% of all patients. No
differences were seen in clinical bone disease, growth Mean differences in Z scores of lumbar spine and femo-
ral neck BMD in patients categorized according to po-and motor handicaps between the total cohort, the parti-
cipants and the non-participants in the cross-sectional tential determinants are given in Table 5.
Multivariate linear stepwise regression analysis re-study (Table 2).
Both clinical bone disease and severe growth retarda- vealed an association between a low BMD Z score of
the lumbar spine on one side, and male gender ( tion were associated with a longer duration of RRT, a
longer duration of dialysis, and an initiation of RRT earlier 0.49, P  0.0001) and physical inactivity (  0.22,
P  0.014) on the other side. A low lean body mass wasin history. Patients with aseptic bone disease had on aver-
age a longer duration of total RRT, a longer time with associated with a low lumbar spine Z-score (  0.46,
P  0.0001), as well as with a low femoral neck Z-scorea well-functioning renal graft, and a start of RRT earlier
in history than patients without aseptic bone necrosis. (  0.41, P  0.0001). If the lean body mass was ex-
cluded from the analysis as a variable, dialysis as theSevere bone disease was more apparent in patients with
a history of severe hyperthyroidism (Table 3). modality of RRT at the time of investigation was associ-
ated with a low femoral neck BMD Z score (  0.18,The occurrence of atraumatic fractures was associated
with longer total dialysis duration. No association was P  0.03). In the multivariate regression analysis height
did not correlate with the Z scores of both BMD values.found between clinical manifestations of bone disease
and the cumulative dosage of steroids. Patients with se- Tables 6 and 7 show the univariate and multivariate
relations between determinants and Z scores of the lum-vere growth retardation tended to have had more ste-
roids than those with normal growth, however, the differ- bar spine and femoral neck BMD. The predicted Z scores
of the lumbar spine and femoral neck BMD of male andence was not statistically significant (Table 3).
female patients, when adjusted for lean body mass are
Bone mineral density given in Table 8.
The mean standard deviation corrected for age and
Medication and its relation to bone mineral densitygender, of the BMD (Z score) of the lumbar spine was
2.12 (SD 1.4), of the femoral neck 1.77 (SD 1.4). For Since all our patients had received aluminum-con-
taining phosphate binders at some point, and the docu-male patients the mean Z score of the BMD of the lumbar
spine was2.38 (SD 1.4) and the femoral neck was1.64 mentation of the dosage proved to be unreliable, further
analysis on these drugs could not be done. Growth hor-(SD 1.3). In female patients the Z-score of the BMD of
the lumbar spine was 1.80 (SD 1.3) and the femoral mone therapy was given to 43 (17.3%) patients. As these
were the first patients in the Netherlands ever to receiveneck was1.86 (SD 1.3). Gender specified BMD, height
and weight values are presented in Table 4. growth hormone therapy on the indication of severe
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Table 2. Growth retardation and clinical manifestations of bone disease of all patients, participants and non-participants of the
cross-sectional study
Total cohorta Participantsb Non-participantsc
N affected
Height 2 SD 153 (61.9%) 83 (59.3%) 31 (66.0%)
Clinical manifestations of bone disease 91 (36.8%) 51 (36.4%) 17 (36.2%)
Deformities 63 (25.5%) 41 (29.3%) 9 (19.1%)
Pathological fractures 33 (13.4%) 16 (11.4%) 8 (17.0%)
Aseptic bone necrosis 32 (13.0%) 16 (11.4%) 8 (17.0%)
Mild disabling bone disease 26 (10.5%) 17 (12.1%)d 4 (8.5%)
Severe disabling bone disease 18 (7.3%) 8 (5.7%)d 3 (6.4%)
Invalidating bone disease (all) 44 (17.8%) 25 (17.9%)d 7 (14.9%)
a N  247; Of two patients, who died in the early 1970s, no data on growth or bone abnormalities could be found
b Participants in the cross-sectional study (N  140)
c Living non-participants in the cross-sectional study (N  47)
d Situation at time of cross-sectional investigation
growth retardation caused by ESRD, this drug also was children, Offner et al report disabilities caused by bone
disease in only three patients [24]. However, data onexcluded from further analysis for reasons of patient
this subject were gathered only by telephone interview,bias. The mean cumulative period of prednisone dosage
which in our experience can easily lead to an underesti-of more than 0.25 mg/kg was 2.63 years (SD 3.02). The
mation of the disability. For example, most of our pa-mean dosage of methylprednisolone was 180 mg/kg. We
tients who were unable to walk for more than 100 m orestimated the overall mean dosage of prednisone to be
to climb a stairway because of severe pain in the hips661 (SD 665) mg/kg over a mean cumulative period of
or knees, first denied having any disability at all. Clinical13.67 (SD 6.44) transplantation years. Although the cu-
manifestations of bone disease, therefore, might be amulative dosage of corticosteroids was not correlated
generally underestimated problem in young adult pa-with BMD of either segment (data not shown), patients
tients with juvenile ESRD.with a history of aseptic bone necrosis had a significant
lower mean Z score of the lumbar spine BMD (differ- Bone mineral density
ence Z score  0.91; P  0.006; Table 5). Patients who Low bone mineral density values were found in nearly
had ever used cyclosporine showed a lower lumbar spine the entire patient cohort. More than 50% of them had
BMD Z score, which was not significant, however, com- a BMD Z score in at least one segment of less than
pared to those on azathioprine (data not shown). 2.5, which is consistent with osteoporosis in otherwise
healthy subjects. The lumbar spine was more severely
affected than the femoral neck. A low BMD of the lum-DISCUSSION
bar spine was associated with a low lean body mass, male
Clinical bone disease gender, physical inactivity and aseptic bone necrosis. A
low BMD of the femoral neck was associated with a lowIn this follow-up study in young adults with ESRD
lean body mass. The effect of lean body mass on BMDsince childhood, we found that one third suffered from
values was more apparent in male than in female patients.clinical manifestations of metabolic bone disease. More
Low BMDs have been reported in dialysis and trans-than one out of six patients was disabled as a result of
planted patients with adult onset of ESRD [1, 3–12].this bone disease and more than 60% were severely
The major structural bone abnormality found in dialysisgrowth retarded. Both growth retardation and clinical
patients is a generalized thinning of cortical bone duebone disease were associated with a long duration of
to increased endocortical resorption [7]. After trans-dialysis, where as aseptic bone necrosis was associated
plantation, an imbalance in bone remodeling character-with a long period of living with a functioning renal graft.
ized by osteoclast stimulation and osteoblast suppres-Growth retardation is a well-known complication of
sion, results in a reduction of trabecular and cortical
ESRD in children [15, 19, 20]. Since we followed a group bone [9–11]. Further, the mineralization is retarded in
of patients who started RRT long before growth hor- transplanted patients. Garlini et al showed that in adults
mone therapy became available, our findings on this the BMD approximates normal value only after 10 years
matter are as expected. However, the extent and severity of successful transplantation [10].
of clinically manifest bone disease in these young pa-
Etiological factors of low bone mineral density intients surprised us. Although bone disease is a well-
renal diseaserecognized problem in ESRD, data on its clinical conse-
quences in young adult patients with juvenile ESRD are A low bone mineral density in ESRD results from a
combination of specific and non-specific consequencesscarce. In their follow-up study of 120 renal transplanted
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Table 4. Weight, height, lean body mass, and bone mineral density
(BMD) of lumbar spine and femoral neck in patients, compared
to healthy subjects
Patients Controls
Male patients (N  73)
Age in years range 20.7–41.7 20–40
Mean height cm 164.7 (SD 9.6) 182.9 (SD 8.0)c
Mean weight kg 63.8 (SD 13.5) 80.4 (SD 9.1)c
Lean body mass kg 47.7 (SD 7.8) 59.1 (SD 7.5)d
Mean BMD, lumbar spine
g/cm2 0.83 (SD 0.15)a 1.09 (SD 0.11)e
Z score BMD, lumbar spine 2.38 (SD 1.4)a 0
Mean BMD, femoral neck
g/cm2 0.76 (SD 0.14)b 0.91 (SD 0.13)e
Z score BMD, femoral neck 1.64 (SD 1.3)b 0
Female patients (N  64)
Mean age in years range 20.8–40.6 20–40
Mean height cm 156.1 (SD 8.9)c 169.3 (SD 4.4)c
Mean weight kg 58.0 (SD 13.4) 67.0 (SD 7.3)c
Lean body mass kg 37.3 (SD 5.6) 42.9 (SD 8.4)d
Mean BMD, lumbar spine
g/cm2 0.84 (SD 0.14)f 1.04 (SD 0.11)e
Z score mean BMD, lumbar
spine 1.80 (SD 1.3)f 0
Mean BMD, femoral neck
g/cm2 0.70 (SD 0.13)f 1.15 (SD 0.14)e
Z score BMD, femoral neck 1.86 (SD 1.3)f 0
Mean values and standard deviations (SD) are given except for age. Z score
is the standard deviation corrected for age and gender.
aN  71; bN  70
cData from Centraal Bureau voor de Statistiek (National Health Statistics:
www.cbs.nl)
dData from Boot el al [23]
eData supplied by Hologic Inc.
fN  63; gN  61
of renal disease. Hyperparathyroidism, the use of corti-
costeroids after transplantation, a low lean body mass,
inactivity, and male gender are thought to be the major
causes of bone loss [2, 5–13, 18–22]. The preferential loss
of cortical bone in dialysis patients is thought to be
caused by hyperparathyroidism. Yet, normalization of
parathormone plasma levels does not induce a reversal of
this cortical thinning in dialysis patients [7]. This explains
why dialysis patients with a low turnover bone disease
with osteomalacia who do not have apparent hyperpara-
thyroidism, can still have severe cortical thinning. In
these patients, the total bone loss is even greater than
in patients with osteitis fibrosa as a result of concurrent
cancellous bone loss [7]. Moreover, patients with a high
turnover bone disease can have a normal or increased
BMD as a result of an increase in yet abnormally struc-
tured osteoid with amorphous calcium depositions [25].
It also might explain why in our patient group the total
duration of apparent hyperparathyroidism was of no ap-
parent influence on the BMD.
The relationship between lean body mass and bone
mass is well established [17, 26–28]. The mechanism is
believed to be partially hormonal and partially mechani-
cal. Muscle increases mechanical load on bones, which
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stimulated bone formation, especially in weight-bearing
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Table 5. Differences in mean bone mineral density (BMD) of the lumbar spine and the femoral neck categorized according to several
potential determinants
BMD lumbar spine BMD femoral neck
Category N Z score (SD) Difference Z score (SD) Difference
Physical inactivity
Yes 33 2.76 (1.2) 0.86b 2.00 (1.4) 0.33
No 103 1.90 (1.4) 1.67 (1.3)
Last RRT
Dialysis 29 2.22 (1.4) 0.14 2.18 (1.2) 0.55b
Transplantation 107 2.08 (1.4) 1.63 (1.3)
Start RRT
1972–1981 74 1.96 (1.4) 0.32 1.68 (1.4) 0.16
1982–1992 62 2.28 (1.4) 1.84 (1.2)
Gender
Male 73 2.37 (1.4) 0.49b 1.66 (1.3) 0.2
Female 63 1.88 (1.3) 1.86 (1.3)
Tx as of last RRT
1 year Tx 4 2.91 (0.9) 0.86 1.73 (1.9) 0.11
1 year Tx 104 2.05 (1.4) 1.62 (1.3)
Tx as of last RRT
3 year Tx 11 2.60 (0.8) 0.59a 1.99 (1.3) 0.41
3 year Tx 96 2.01 (1.4) 1.58 (1.3)
Aseptic bone necrosis
Yes 16 2.91 (1.3) 0.91b 2.13 (1.3) 0.42
No 120 2.00 (1.3) 1.71 (1.3)
Menarche
15th year 32 1.78 (1.3) 0.28 1.70 (1.2) 0.5
16th year 29 2.06 (1.2) 2.20 (1.3)
Severe hyperparathyroidism
Yes 63 2.32 (1.3) 0.41 1.74 (1.3) 0.07
No 72 1.91 (1.3) 1.81 (1.3)
Abbreviations are: RRT, renal replacement therapy; Tx, transplantation; SD, standard deviation; Z score, standard deviation corrected for age and gender.
aP  0.05; bP  0.01; cData from a cross-sectional study
Table 6. Pearson’s correlations (R) between the lumbar spine and in our study is in accordance with the results of the study
the femoral neck bone mineral densities (BMD) Z scores
by Cueto-Manzano et al [11]. They investigated the ex-and determinants
tent of bone loss in long-term renal transplant patients
Z score BMD Z score BMD and found male gender even to be the strongest pre-lumbar spine: R femoral neck: R
dictive factor for a low bone mass [11]. It is unclear to
Physical inactivity 0.27c 0.12
what extent gender differences in loss of lean body massDialysis at time of investigation 0.18b
Start RRT 1972–1981 played a role in their study. The effect of physical inactiv-
vs. 1982–1992 0.12 ity on bone loss is well documented in the literature, asMale gender 0.2b
is the reversibility by exercise. Soderman et al foundAseptic bone necrosis 0.21b
Age of menarche 0.18 increased BMD values of the total body, the lumbar
Body height 0.15 0.25c spine and all sites of the hip in adolescent female soccerLean body massa 0.16 0.41d
players, compared to non-active controls [14]. Slemenda
Note: Only characteristics significant at the P  0.2 level are shown.
et al showed that there was a direct relationship betweena Assessed by DEXA
b P  0.05; cP  0.01; dP  0.001 the total hours of weight-bearing activity in children and
increase in BMD in the hip [13]. Spindler et al showed
that in hemodialysis patients the increase in femoral neck
BMD also was correlated with increase in muscularbones. The fact that lean body mass correlates better
strength of the proximal muscles [26]. Our findings stresswith bone mass than total body weight supports the as-
the importance of physical activity in these patients, whosumption of an additional hormonal factor. In our pa-
tend to be more inactive than average.tients, the low lean body mass accounted for an impor-
Corticosteroids enhance resorption and reduce forma-tant part of the low bone density values, especially in
tion of mainly trabecular bone, which is the primarymales. However, even after correction for lean body
component of the human vertebrae. Boot et al foundmass, the decrease in BMD of the lumbar spine was still
reduced lumbar spine BMD in 20 young adults whomore severe than in patients with adult onset of ESRD
received a renal transplant. This reduction was directly[10–12]. This counted for males as well as for females.
The fact that males than females were more affected correlated to the cumulative steroid-dosage [18]. Con-
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Table 8. Predicted Z score of bone mineral density values whenTable 7. Multivariate linear regression stepwise analysis to describe
the relation between the lumbar spine and femoral neck bone adjusted for lean body mass
mineral density (BMD) Z-scores and its determinants:
Female patients Male patientsStandardized coefficients ()
Regression coefficientZ score BMD Z score BMD
lumbar spine 0.07 0.08lumbar spine femoral neck
Z score BMD,
lumbar spine 1.80 (SD 1.3) 2.38 (SD 1.4)b
Predicted Z score BMD,
Physical inactivity 0.22b lumbar spine after
Male gender 0.49c correction for lean
Lean body massa 0.46c 0.41c body mass 1.34 (SD 1.2) 1.48 (SD 1.2)
Regression coefficient,Note: Only characteristics significant at the P 0.05 level are shown. Excluding
lean body mass and height as determinants revealed dialysis at time of investiga- femoral neck 0.05 0.1
tion negatively associated with BMD femoral neck Z score (  0.18, P  Z score BMD,
0.03): Z score is the standard deviation corrected for age and gender. femoral neck 1.86 (SD 1.3) 1.64 (SD 1.3)
a Assessed by DEXA Predicted Z score BMD,b P  0.01; cP  0.001
femoral neck after
correction for lean
body mass 1.60 (SD 1.2) 0.52 (SD 1.1)
trary to these results, we found no direct relationship
between corticosteroid dosage and BMD of the lumbar
spine. One explanation could lie in the fact that the mean normal structured lamellar osteoid, mineralized with
amorphous deposed calcium rather than as hydroxyapa-steroid dosage in their population was 1186 mg/kg, that
is, nearly twice as much as used by our patients. On the tite [25]. In patients with these severe structural matrix
disorders, the BMD can be normal or even high. On theother hand, some of our results indirectly suggest the
influence of steroids on bone mass. Patients who were other hand, a low BMD in children and adolescents could
be due either to an insufficient mineralization (mineraltransplanted less than three years before the DEXA
examination showed a 32% lower BMD of the lumbar per volume) or to a reduced structural density (that is,
a decreased trabecular thickness) as a result of inactivityspine compared to patients who had lived for more than
three years with a renal graft at time of investigation. or muscular dysfunction [25]. Whether the low BMD
values in patients with ESRD since childhood implicateThis difference could reflect the more recent use of high
dose steroids in the first group, implying that this bone the same increased risk of atraumatic and potentially
debilitating fractures as in ESRD patients with adultloss is reversible. This finding is compatible with data of
Cueto-Manzano et al, who also found less reduction of onset, therefore, is speculative at present. No follow-up
studies on this subject have been published. However,bone mass in long-term renal transplanted adult patients
compared to short-term reports [11]. Other circumstan- there are some important arguments in favor of this
relationship. First, it is well established that bone masstial evidence of the relationship between steroids and
bone density in our study can be derived from the link later in life is determined by the peak bone mass acquired
during adolescence, and that consequently a low peakfound between a history of aseptic bone necrosis and
low lumbar spine BMD. bone mass results in a higher risk of osteoporosis [29,
30, 33]. Obviously, the mean peak bone mass in our
The impact of low bone mineral density patient group was low. Second, it is also well demon-
strated that patients with a low bone mass as a result ofEnd-stage renal disease in older patients goes with an
increased risk of fractures. A direct relation between a low lean body mass or inactivity are at higher risk
for fractures [31–33]. Third, it is well established thatlow BMD and increased risk of fractures has been estab-
lished in older dialysis patients, as well as in older renal malnutrition, inactivity, and the use of corticosteroids
during childhood and growth retardation all put patientstransplanted patients [3, 8, 12]. Atsumi et al found a
double risk for vertebral fractures for each standard devi- at risk for osteoporosis [33]. A prolonged follow-up of
the cohort is warranted to enact the actual impact of ouration decrease in bone mineral density of the lumbar
spine [8]. The prevalence of vertebral fractures in this findings on the incidence of fractures.
study ranged from 10% in the group aged 30 to 39 years
Limitations of the studyto 34.5% in the age group 60 to 69 years. In transplanted
patients, a triple fracture rate has been reported [12]. Evaluation of some potential determinants was some-
times cumbersome (for example, hyperparathyroidism)Yet, interpretation of the low BMD values found in
our patients is difficult. Scho¨nau pointed out the prob- or impossible (such as, aluminum-containing phosphate
binders and vitamin D preparations), due to the retro-lems of non-invasive bone analysis in children and ado-
lescents [25]. For instance, hyperparathyroidism in chil- spective character of that part of the study. Beside the
limitation of bone mass measurement using DEXA only,dren can lead to the formation of woven instead of
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